| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,620 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,387,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,620 |
|
|
| Total
Value |
$6,387,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-03-15 |
71,467 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
172 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial OfOffice |
• – – |
2012-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,570 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-10-30 |
4 |
A |
$57.26 |
$1,489 |
D/D |
26 |
35,631 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-11-02 |
4 |
AS |
$117.56 |
$3,057 |
D/D |
(26) |
35,605 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-10-31 |
4 |
A |
$31.26 |
$1,469 |
D/D |
47 |
31,637 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-11-03 |
4 |
AS |
$83.54 |
$3,926 |
D/D |
(47) |
31,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-10-31 |
4 |
A |
$27.91 |
$2,763 |
D/D |
99 |
14,979 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-11-01 |
4 |
AS |
$63.16 |
$6,253 |
D/D |
(99) |
14,880 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2012-10-31 |
4 |
A |
$21.76 |
$5,766 |
D/D |
265 |
10,835 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2012-11-12 |
4 |
S |
$48.11 |
$12,750 |
D/D |
(265) |
10,570 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-31 |
4 |
D |
$62.70 |
$18,622 |
D/D |
(297) |
15,373 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
51,834 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-02 |
4 |
AS |
$96.74 |
$29,215 |
D/D |
(302) |
51,532 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
53,223 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-05-07 |
4 |
AS |
$85.96 |
$26,562 |
D/D |
(309) |
52,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
61,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-04-28 |
4 |
A |
$66.88 |
$21,267 |
D/D |
318 |
65,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-30 |
4 |
A |
$62.59 |
$21,154 |
D/D |
338 |
63,402 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-04-29 |
4 |
A |
$62.41 |
$21,218 |
D/D |
340 |
55,417 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-04-30 |
4 |
A |
$62.41 |
$21,343 |
D/D |
342 |
58,592 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-06-02 |
4 |
AS |
$57.83 |
$21,804 |
D/D |
(377) |
20,190 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-06-01 |
4 |
AS |
$123.76 |
$46,657 |
D/D |
(377) |
38,455 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-31 |
4 |
D |
$57.96 |
$23,937 |
D/D |
(413) |
20,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-05-31 |
4 |
D |
$125.57 |
$51,860 |
D/D |
(413) |
38,832 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
63,487 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-03 |
4 |
AS |
$86.03 |
$35,701 |
D/D |
(415) |
63,072 |
0 |
- |
|
172 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
